Dr. Wilson Publishes Three Articles Discussing Cosmetic Injectables
Our extensively trained plastic surgeons are dedicated to providing unsurpassed treatment using the most advanced techniques available. With this goal in mind, our own Dr. Anthony Wilson has recently published three articles discussing the benefits of and optimal applications for many popular cosmetic injectables. In these pieces, he compares several formulas, including BOTOX® Cosmetic, JUVÉDERM®, and Restylane®, to name a few.
We understand that the general public does not commonly read medical journals; however, we believe that by sharing this information with our patients they will benefit from knowing our surgeons are continuing to learn as well as continuing to educate colleagues and the next generation of doctors. Your results, experience, and safety are our highest priorities, and we strive to provide the best possible care while you’re in our hands.
In “Current Applications of Facial Volumization of Fillers,” published in Plastic and Reconstructive Surgery®, the journal of the American Society of Plastic Surgeons, Dr. Wilson identifies how to best evaluate and treat patients seeking facial rejuvenation after volume loss. This article is designed to assist experienced injectors in achieving the desired outcome with the most natural-looking result possible. He underscores the importance of customizing treatment, particularly in determining the anatomical areas to target and choosing the most appropriate dermal filler(s) for the patient’s needs.
In “A Quantitative Analysis of OnabotulinumtoxinA, AbobotulinumtoxinA, and IncobotulinumtoxinA: A Randomized, Double-Blind, Prospective Clinical Trial of Comparative Dynamic Strain Reduction,” also published in the journal of the American Society of Plastic Surgeons, Dr. Wilson focuses on the neuromodulators BOTOX® Cosmetic, Dysport®, and Xeomin®. This research was designed to compare the efficacy of each of these products and determine whether there were enough differences between the formulas to warrant additional study.
In “Patient Perceived benefit in Facial Aesthetic Procedures: FACE-Q as a Tool to Study Botulinum Toxin Injection Outcomes,” published in the Aesthetic Surgery Journal, Dr. Wilson discusses whether the FACE-Q tool can objectively assess patient satisfaction following cosmetic neuromodulator treatment. The FACE-Q is a type of survey patients complete before and after injection, which can demonstrate whether satisfaction with their appearance has changed.
If you have any questions about Dr. Wilson’s work with cosmetic injectables, or if you would like to know more about his research, please contact our practice today, and we’ll be happy to help.